UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...

Misuse and Diversion of Stimulants Prescribed for ADHD: A Systematic Review of the Literature

Journal of the American Academy of Child and Adolescent Psychiatry, 2008, Vol.47 (1), p.21-31

2008

Link zum Volltext

Verfügbarkeit prüfen

Barriers and facilitators affecting the implementation of substance use screening in primary care clinics: a qualitative study of patients, providers, and staff

Addiction science & clinical practice, 2018-04, Vol.13 (1), p.8-8, Article 8

2018

Link zum Volltext

Verfügbarkeit prüfen

A 3' UTR SNP rs885863, a cis-eQTL for the circadian gene VIPR2 and lincRNA 689, is associated with opioid addiction

PloS one, 2019-11, Vol.14 (11), p.e0224399

2019

Link zum Volltext

Verfügbarkeit prüfen

A Brief Patient Self-administered Substance Use Screening Tool for Primary Care: Two-site Validation Study of the Substance Use Brief Screen (SUBS)

The American journal of medicine, 2015-07, Vol.128 (7), p.784.e9-784.e19

2015

Link zum Volltext

Verfügbarkeit prüfen

A non-coding CRHR2 SNP rs255105, a cis-eQTL for a downstream lincRNA AC005154.6, is associated with heroin addiction

PloS one, 2018-06, Vol.13 (6), p.e0199951

2018

Link zum Volltext

Verfügbarkeit prüfen

Optimizing the use of ketamine to reduce chronic postsurgical pain in women undergoing mastectomy for oncologic indication: study protocol for the KALPAS multicenter randomized controlled trial

Trials, 2024-01, Vol.25 (1), p.67-67, Article 67

2024

Link zum Volltext

Verfügbarkeit prüfen

Prior National Drug Abuse Treatment Clinical Trials Network (CTN) opioid use disorder trials as background and rationale for NIDA CTN-0100 "optimizing retention, duration and discontinuation strategies for opioid use disorder pharmacotherapy (RDD)"

Addiction science & clinical practice, 2021-03, Vol.16 (1), p.15-15, Article 15

2021

Link zum Volltext

Verfügbarkeit prüfen

Test–retest reliability of a self-administered Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) in primary care patients

Journal of substance abuse treatment, 2014-07, Vol.47 (1), p.93-101

2014

Link zum Volltext

Verfügbarkeit prüfen

Where’s Our Lin Zexu? A Call for Leadership and Resources to Address the Opioid Epidemic

The American journal of psychiatry, 2018-06, Vol.175 (6), p.495-497

Rotrosen, John

2018

Link zum Volltext

Verfügbarkeit prüfen

Implementation of substance use screening in rural federally-qualified health center clinics identified high rates of unhealthy alcohol and cannabis use among adult primary care patients

Addiction science & clinical practice, 2023-09, Vol.18 (1), p.56-56, Article 56

2023

Link zum Volltext

Verfügbarkeit prüfen

Brain macrostructural and microstructural abnormalities in cocaine dependence

Drug and alcohol dependence, 2008-01, Vol.92 (1), p.164-172

2008

Link zum Volltext

Verfügbarkeit prüfen

Under-representation of key demographic groups in opioid use disorder trials

Drug and alcohol dependence reports, 2022-09, Vol.4, p.100084, Article 100084

2022

Link zum Volltext

Verfügbarkeit prüfen

A preliminary study of the effects of individual patient-level feedback in outpatient substance abuse treatment programs

Journal of substance abuse treatment, 2012-04, Vol.42 (3), p.301-309

2012

Link zum Volltext

Verfügbarkeit prüfen

Reduced frontal white matter integrity in cocaine dependence: a controlled diffusion tensor imaging study

Biological psychiatry (1969), 2002-06, Vol.51 (11), p.890-895

2002

Link zum Volltext

Verfügbarkeit prüfen

NIDA Clinical Trials Network CTN-0051, Extended-Release Naltrexone vs. Buprenorphine for Opioid Treatment (X:BOT): Study design and rationale

Contemporary clinical trials, 2016-09, Vol.50, p.253-264

2016

Link zum Volltext

Verfügbarkeit prüfen

Commitment to assessment and treatment: comprehensive care for patients gravely disabled by alcohol use disorders

The Lancet (British edition), 2013-09, Vol.382 (9896), p.995-997

2013

Link zum Volltext

Verfügbarkeit prüfen

Time-lagged association between counseling and/or 12-Step attendance with subsequent opioid use in a secondary analysis from a randomized, clinical trial of medications for opioid use disorder

Drug and alcohol dependence reports, 2022-12, Vol.5, p.100100, Article 100100

2022

Link zum Volltext

Verfügbarkeit prüfen

Specific polysubstance use patterns predict relapse among patients entering opioid use disorder treatment

Drug and alcohol dependence reports, 2022-12, Vol.5, p.100128, Article 100128

2022

Link zum Volltext

Verfügbarkeit prüfen

Inferior Frontal White Matter Anisotropy and Negative Symptoms of Schizophrenia: A Diffusion Tensor Imaging Study

The American journal of psychiatry, 2003-03, Vol.160 (3), p.572-574

2003

Link zum Volltext

Verfügbarkeit prüfen

Implementation facilitation to introduce and support emergency department-initiated buprenorphine for opioid use disorder in high need, low resource settings: protocol for multi-site implementation-feasibility study

Addiction science & clinical practice, 2021-03, Vol.16 (1), p.16-16, Article 16

2021

Link zum Volltext

Verfügbarkeit prüfen

Substance-use screening and interventions in dental practices: survey of practice-based research network dentists regarding current practices, policies and barriers

The Journal of the American Dental Association (1939), 2013-06, Vol.144 (6), p.627

2013

Link zum Volltext

Verfügbarkeit prüfen

Smoking cessation treatment in community-based substance abuse rehabilitation programs

Journal of substance abuse treatment, 2008-07, Vol.35 (1), p.68-77

2008

Link zum Volltext

Verfügbarkeit prüfen

Menstrual cycle phase effects on prepulse inhibition of acoustic startle

Psychophysiology, 2004-05, Vol.41 (3), p.401-406

2004

Link zum Volltext

Verfügbarkeit prüfen

Extended-release naltrexone plus medical management alcohol treatment in primary care: findings at 15 months

Journal of substance abuse treatment, 2012-12, Vol.43 (4), p.458-462

2012

Link zum Volltext

Verfügbarkeit prüfen

Extended-release naltrexone for treatment of alcohol dependence in primary care

Journal of substance abuse treatment, 2010-07, Vol.39 (1), p.14-21

2010

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 304

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(282)
Mit Volltextzugriff
(270)

Publikationsform

Sprache

Englisch
(304)

Erscheinungsjahr

n.n

Thema

Science & Technology
(233)
Life Sciences & Biomedicine
(231)
Humans
(222)
Male
(153)
Psychiatry
(131)
Adult
(120)
Female
(97)
Biological And Medical Sciences
(94)
Middle Aged
(85)
Medical Sciences
(84)
Substance Abuse
(76)
Neurosciences & Neurology
(57)
Psychology. Psychoanalysis. Psychiatry
(56)
Pharmacology & Pharmacy
(54)
Neurosciences
(51)
Substance Abuse Treatment
(49)
Psychopathology. Psychiatry
(43)
Drug Abuse
(42)
Narcotics
(40)
Opioid-Related Disorders - Drug Therapy
(40)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Misuse and Diversion of Stimulants Prescribed for ADHD: A Systematic Review of the Literature

Barriers and facilitators affecting the implementation of substance use screening in primary care clinics: a qualitative study of patients, providers, and staff

A 3' UTR SNP rs885863, a cis-eQTL for the circadian gene VIPR2 and lincRNA 689, is associated with opioid addiction

A Brief Patient Self-administered Substance Use Screening Tool for Primary Care: Two-site Validation Study of the Substance Use Brief Screen (SUBS)

A non-coding CRHR2 SNP rs255105, a cis-eQTL for a downstream lincRNA AC005154.6, is associated with heroin addiction

Optimizing the use of ketamine to reduce chronic postsurgical pain in women undergoing mastectomy for oncologic indication: study protocol for the KALPAS multicenter randomized controlled trial

Prior National Drug Abuse Treatment Clinical Trials Network (CTN) opioid use disorder trials as background and rationale for NIDA CTN-0100 "optimizing retention, duration and discontinuation strategies for opioid use disorder pharmacotherapy (RDD)"

Test–retest reliability of a self-administered Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) in primary care patients

Where’s Our Lin Zexu? A Call for Leadership and Resources to Address the Opioid Epidemic

Implementation of substance use screening in rural federally-qualified health center clinics identified high rates of unhealthy alcohol and cannabis use among adult primary care patients

Brain macrostructural and microstructural abnormalities in cocaine dependence

Under-representation of key demographic groups in opioid use disorder trials

A preliminary study of the effects of individual patient-level feedback in outpatient substance abuse treatment programs

Reduced frontal white matter integrity in cocaine dependence: a controlled diffusion tensor imaging study

NIDA Clinical Trials Network CTN-0051, Extended-Release Naltrexone vs. Buprenorphine for Opioid Treatment (X:BOT): Study design and rationale

Commitment to assessment and treatment: comprehensive care for patients gravely disabled by alcohol use disorders

Time-lagged association between counseling and/or 12-Step attendance with subsequent opioid use in a secondary analysis from a randomized, clinical trial of medications for opioid use disorder

Specific polysubstance use patterns predict relapse among patients entering opioid use disorder treatment

Inferior Frontal White Matter Anisotropy and Negative Symptoms of Schizophrenia: A Diffusion Tensor Imaging Study

Implementation facilitation to introduce and support emergency department-initiated buprenorphine for opioid use disorder in high need, low resource settings: protocol for multi-site implementation-feasibility study

Substance-use screening and interventions in dental practices: survey of practice-based research network dentists regarding current practices, policies and barriers

Smoking cessation treatment in community-based substance abuse rehabilitation programs

Menstrual cycle phase effects on prepulse inhibition of acoustic startle

Extended-release naltrexone plus medical management alcohol treatment in primary care: findings at 15 months

Extended-release naltrexone for treatment of alcohol dependence in primary care

Suchergebnisse filtern